Oxygen metabolites and vascular damage

Inflammatory Diseases of Blood Vessels

Volumn , Issue , 2016, Pages 83-96

  Mcintyre, Thomas M ^a   Marathe, Gopal K ^a   Zimmerman, Guy A ^a   Prescott, Stephen M ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0009021714     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (94)

1. Collins, T. Endothelial nuclear factor-kB and the initiation of the atherosclerotic lesion. Lab Invest 1995; 68:499-508.
2. Sen, CK, and L Packer. Antioxidant and redox regulation of gene transcription. FASEB J 1996; 10: 709-720.
3. Gurtner, GH, and T Burke-Wolin. Interactions of oxidant stress and vascular reactivity. Am J Physiol 1991; 260:L207-211.
4. Cohnheim, J. Lectures on General Pathology: A Handbook for Practitioners and students. London: The New Sydenham Society, 1889.
5. Jaffe, EA, RL Nachman, CG Becker, and CR Minick. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52:2745-2756.
6. Zimmerman, GA, RE Whatley, TM Mcintyre, DM Benson, and SM Prescott. Endothelial cells for studies of platelet-activating factor and arachidonate metabolites. Methods Enzymol 1990; 187:520535.
7. Ley, K. Gene-targeted mice in leukeyte adhesion research. Microcirculation 1995; 2:141-150.
8. Wu, KK. Injury-coupled induction of endothelial eNOS and COX-2 genes: A paradigm for thromboresistant gene therapy. Proc Assoc Am Physicians 1998; 110: 163-170.
9. Feletou, M, and PM Vanhoutte. The alternative: EDHF. J Mol Cell Cardiol 1999; 31: 15-22.
10. Cines, DB, ES Pollak, CA Buck, J Loscalzo, GA Zimmerman, RP McEver, JS Pober, TM Wick, BA Konkle, BS Schwartz, ES Barnathan, KR McCrae, BA Hug, AM Schmidt, and DM Stem. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91 :3527-3561.
11. McIntyre, TM, V Modur, SM Prescott, and GA Zimmerman. Molecular mechanisms of early inflammation. Thromb Haemost 1997; 78:302-305.
12. Zimmerman, GA, TM McIntyre, and SM Prescott. Adhesion and signaling in vascular cell-cell interactions. J Clin Invest 1997; 100:S3-5.
13. Zimmerman, GA, SM Prescott, and TM McIntyre. Endothelial cell interactions with granulocytes: Tethering and signaling molecules. Immunol Today 1992; 13:93-100.
14. Lorant, DE, KD Patel, TM McIntyre, RP McEver, SM Prescott, and GA Zimmerman. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: A juxtacrine system for adhesion and activation of neutrophils. J Cell Bioi 1991 ; 115:223-234.
15. Springer, TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994; 76:301-314.
16. Powell, LD, and A Varki. I-type lectins. J Bioi Chern 1995; 270:14243-14246.
17. Moore, KL, KD Patel, RE Bruehl, L Fugang, DA Johnson, HS Lichenstein, RD Cummings, DF Bainton, and RP McEver. P-selectin glycoprotein ligand-I mediates rolling of human neutrophils on P-selectin. J Cell Bioi 1995; 128:661-671.
18. Mehta, P, RD Cummings, and RP McEver. Affinity and kinetic analysis of P-selectin binding to P-selectin glycoprotein ligand-I. J BioI Chern 1998; 273:32506-32513.
19. Benveniste, J, PM Henson, and C Cochrane. Leukocyte-dependent histamine release from rabbit platelets: The role for IgE, basophils and a platelet-activating factor. J Exp Med 1972; 136: 1356-1375.
20. Blank, ML, F Snyder, LW Byers, B Brooks, and EE Muirhead. Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. Bioch Biophys Res Comm 1979; 90: 1194-1200.
21. Prescott, SM, TM McIntyre, and GA Zimmerman. Platelet-activating factor: A phospholipid mediator of inflammation. In: 11 Gallin, and R Snyderman, eds. Inflammation: Basic Principles and Clinical Correlates. Philadelphia: Lippincott Williams & Wilkins, 1999:387-396.
22. Honda Z, M Nakamura, I Miki, M Minami, T Watanabe, Y Seyama, H Okado, H Toh, K Ito, T Miyamoto, and T Shimizu. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 1991; 349:342-346.
23. McIntyre, TM, GA Zimmerman, and SM Prescott. Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc Natl Acad Sci USA 1986; 83:2204-2208.
24. McEver, RP. Regulation of function and expression of P-selectin. Agents Actions [Suppl] 1995; 47: 117-119.
25. Whatley, RE, P Nelson, GA Zimmerman, DL Stevens, CJ Parker, TM McIntyre, and SM Prescott. The regulation of platelet-activating factor production in endothelial cells. J Bioi Chern 1989; 264:63256333.
26. Holland, MR, ME Venable, RE Whatley, GA Zimmerman, TM Mcintyre, and SM Prescott. Activation of the acetyl-coenzyme A: Lysoplatelet-activating factor acetyltransferase regulates platelet-activating factor synthesis in human endothelial cells. J Bioi Chern 1992; 267:22883-22890.
27. Fijnheer, R, CJ Frijns, J Korteweg, H Rommes, JH Peters, JJ Sixma, and HK Nieuwenhuis. The origin of P-selectin as a circulating plasma protein. Thromb Haemost 1997; 77: 1081-1085.
28. Sakai, A, N Kume, E Nishi, K Tanoue, M Miyasaka, and T Kita. P-selectin and vascular cell adhesion molecule-l are focally expressed in aortas of hypercholesterolemic rabbits before intimal accumulation of macrophages and T lymphocytes. Arterioscler Thromb Vasc Bioi 1997; 17:310-316.
29. Stafforini, DM, TM McIntyre, GA Zimmerman, and SM Prescott. Platelet-activating factor acetylhydrolases. J BioI Chern 1997; 272:17895-17898.
30. Ostrovsky, L, AJ King, S Bond, D Mitchell, DE Lorant, GA Zimmerman, R Larsen, XF Niu, and P Kubes. Ajuxtacrine mechanism for neutrophil adhesion on platelets involves platelet-activating factor and a selectin-dependent activation proceβs. B109d J 1998;91:3028-3036.
31. Lehr, HA, AM Olofsson, TE Carew, P Vajkoczy, UH von Andrian, C Hubner, MC Berndt, D Steinberg, K Messmer, and KE Arfors. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest 1994; 71 :380386.
32. Weyrich, AS, TM McIntyre, RP McEver, SM Prescott, and GA Zimmerman. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-a secretion: Signal integration and NF-kB translocation. J C1in Invest 1995; 95:2297-2303.
33. Weyrich, AS, MR Elstad, RP McEver, TM McIntyre, KL Moore, JH Morrissey, SM Prescott, and GA Zimmerman. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 1996; 97: 1525-1534.
34. Lehr, HA, C Hubner, B Finckh, S Angermuller, D Nolte, U Beisiege1, A Kohlschutter, and K Messmer. Role of 1eukotrienes in leukocyte adhesion after systemic administration of oxidatively modified human low density lipoprotein in hamsters. J Clin Invest 1991; 88:9-14.
35. Davenpeck, KL, TW Gauthier, KH Albertine, and AM Lefer. Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischemia-reperfusion. Am J Physiol 1994; 267:H622630.
36. Morrow, JD, Y Chen, CJ Brame, J Yang, SC Sanchez, J Xu, WE Zackert, JA Awad, and LJ Roberts. The isoprostanes: Unique prostaglandin-like products offree-radical-initiated lipid peroxidation. Drug Metab Rev 1999; 31: 117-139.
37. Morrow, JD, and LJ Roberts. The isoprostanes: Unique bioactive products of lipid peroxidation. Prog Lipid Res 1997; 36:1-21.
38. Harrison, KA, and RC Murphy. Iso1eukotrienes are biologically active free radical products of lipid peroxidation. J Bioi Chern 1995; 270:17273-17278.
39. Brame, CJ, RG Salomon, JD Morrow, and LJ Roberts II. Identification of extremely reactive gammaketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their Iysyl protein adducts. J Bioi Chern 1999; 274:13139-13146.
40. Morrow, JD, KE Hill, RF Burk, TM Nammour, KF Badr, and LJ Roberts. A series of prostaglandin F2like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990; 87:9383-9387.
41. Morrow, JD, KE Hill, RF Burk, TM Nammour, KF Badr, and LJD Roberts. Formation of unique biologically active prostaglandins in vivo by a non-cyclooxygenase free radical catalyzed mechanism. Adv Prostaglandin Thromboxane Leukotriene Res 1991; 2IA:125-128.
42. Pratico, D, JA Lawson, and GA FitzGerald. Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2 alpha. J Bioi Chern 1995; 270:9800-9808.
43. Catella, F, MP Reilly, N Delanty, JA Lawson, N Moran, E Meagher, and GA FitzGerald. Physiological formation of 8-epi-PGF2 alpha in vivo is not affected by cyclooxygenase inhibition. Adv Prostaglandin Thromboxane Leukotriene Res 1995; 23:233-236.
44. Morrow, JD, and LJ Roberts II. Mass spectrometric quantification ofF2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol 1999; 300:3-12.
45. Morrow, JD, WE Zackert, JP Yang, EH Kurhts, D Callewaert, R Dworski, K Kanai, D Taber, K Moore, J.A. Oates, and LJ Roberts. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-isoPGF2alpha) by a stable isotope dilution mass spectrometric assay. Anal Biochem 1999; 269:326331.
46. Lynch, SM, JD Morrow, LJ Roberts II, and B Frei. Formation of non-cyclooxygenase-derived prostanoids (Fz-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest 1994; 93:998-1004.
47. Pratico, D, RK Tangirala, DJ Rader, J Rokach, and GA FitzGerald. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med 1998; 4: 1189-1192.
48. Delanty, N, MP Reilly, D Pratico, JA Lawson, JF McCarthy, AE Wood, ST Ohnishi, DJ Fitzgerald, and GA FitzGerald. 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 1997; 95:2492-2499.
49. Morrow, JD, B Frei, AW Longmire, JM Gaziano, SM Lynch, Y Shyr, WE Strauss, JA Oates, and LJ Roberts. Increase in circulating products of lipid peroxidation (Fz-isoprostanes) in smokers. N Engl J Med 1995; 332:1198-1203.
50. Reilly, M, N Delanty, JA Lawson, and GA FitzGerald. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996; 94: 19-25.
51. Pryor, WA, and K Stone. Oxidants in cigarette smoke. Ann NY Acad Sci 1993; 686:12-28.
52. Miller, ER III, LJ Appel, L Jiang, and TH Risby. Association between cigarette smoking and lipid peroxidation in a controlled feeding study. Circulation 1997; 96:1097-1101.
53. Markesbery, WR, and JM Carney. Oxidative alterations in Alzheimer's disease. Brain Pathol 1999; 9: 133-146.
54. Montine, TJ, MF Beal, D Robertson, ME Cudkowicz, I Biaggioni, H O'Donnell, WE Zackert, LJ Roberts, and JD Morrow. Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease. Neurology 1999; 52: 1104-1105.
55. Gniwotta, C, JD Morrow, LJ Roberts, 2nd, and H Kuhn. Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arterioscler Thromb Vasc Bioi 1997; 17:3236-3241.
56. Stremler, KE, DM Stafforini, SM Prescott, GA Zimmerman, and TM McIntyre. An oxidized derivative ofphosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. J Bioi Chern 1989; 264:5331-5334.
57. Stremler, KE, DM Stafforini, S.M. Prescott, and TM McIntyre. Human plasma platelet-activating factor acetylhydrolase: Oxidatively-fragmented phospholipids as substrates. J BioI Chern 1991; 266:11095-11103.
58. Watson, AD, N Leitinger, M Navab, KF Faull, S Horkko, JL Witztum, W Palinski, D Schwenke, RG Salomon, W Sha, G Subbanagounder, AM Fogelman, and JA Berliner. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J BioI Chern 1997; 272:13597-135607.
59. Takahashi, K, TM Nammour,MFukunaga, J Ebert, JD Morrow, LJD Roberts, RL Hoover, and KF Badr. Glomerular actions ofa free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. J Clin Invest 1992; 90: 136-141.
60. Lahaie, I, P Hardy, X Hou, H Hassessian, P Asselin, P Lachapelle, G Almazan, DR Varma, JD Morrow, LJ Roberts, 2nd, and S Chemtob. A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels. Am J Physiol 1998; 274:R1406-1416.
61. Kromer, BM, and JR Tippins. Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha. Br J Pharmacol 1996; 119:1276-1280.
62. Kunapuli, P, JA Lawson, JA Rokach, JL Meinkoth, and GA FitzGerald. Prostaglandin F2alpha (PGF2alpha) and the isoprostane, 8,12-iso-isoprostane F2alpha-III, induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathways. J BioI Chern 1998; 273:22442-22452.
63. Jones, DA, DP Carlton, TM McIntyre, GA Zimmerman, and SM Prescott. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J BioI Chern 1993; 268:9049-9054.
64. Martens, JS, M Lougheed, A Gomez-Munoz, and UP Steinbrecher. A modification of apolipoprotein B accounts for most of the induction of macrophage growth by oxidized low density lipoprotein. J Bioi Chern 1999; 274:10903-10910.
65. Steinbrecher, UP, S Parthasarathy, DS Leake, JL Witztum, and D Steinberg. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation ofLDL phospholipids. Proc Natl Acad Sci USA 1984; 81:3883-3887.
66. Horkko, S, E Miller, DW Branch, W Palinski, and JL Witztum. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein I (and other proteins). Proc Natl Acad Sci USA 1997; 94: 10356-103561.
67. Stafforini, DM, SM Prescott, and TM Mcintyre. Human plasma platelet-activating factor acetylhydrolase: Purification and properties. J Bioi Chern 1987; 262:4223-4230.
68. Tjoelker, LW, C Wilder, C Eberhardt, DM Stafforini, G Dietsch, B Schimpf, S Hooper, H Le Trong, LS Cousens, GA Zimmerman, Y Yamada, TM McIntyre, SM Prescott, and PW Gray. Anti-inflammatory properties of a PAF acetylhydrolase. Nature 1995; 374:549-553.
69. Matsuzawa, A, K Hattori, J Aoki, HArai, and K Inoue. Protection against oxidative stress-induced cell death by intracellular PAF-acetylhydrolase II. J Bioi Chern 1997; 272:32315-32320.
70. Marathe, GK, S Davies, KA Harrison, et al. Inflammatory platelet-activating factor-like phospholipids in oxidized low-density liporoteins are fragmented alkyl phosphatidyl cholines. J Bioi Chern 1999; 247:28395-28404.
71. Smiley, PL, KE Stremler, SM Prescott, GA Zimmerman, and TM McInytre. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor. J Bioi Chern 1991; 266: 11104-11110.
72. Whatley, RE, KL Clay, FH Chilton, M Triggiani, GA Zimmerman, TM McIntyre, and SM Prescott. Relative amounts of I-O-alkyl-and l-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells. Prostaglandins 1992; 43:21-29.
73. Tokumura, A, K Kamiyasu, K Takauchi, and H Tsukatani. Evidence for existence of various homologues and analogues of platelet activating factor in a lipid extract of bovine brain. Biochem Biophys Res Comm 1987; 145:415-425.
74. Patel, KD, GA Zimmerman, SM Prescott, and TM McIntyre. Novel leukocyte agonists are released by endothelial cells exposed to peroxide. J Bioi Chern 1992; 267:15168-15175.
75. Heery, JM, M Kozak, DM Stafforini, DA Jones, GA Zimmerman, TM McIntyre, and SM Prescott. Oxidatively modified LDL contains phospholipids with PAF-like activity and stimulates the growth of smooth muscle cells. J Clin Invest 1995; 96:2322-2330.
76. Church, DF, and WA Pryor. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985; 64:111-126.
77. Lehr, H-A. Adhesion-promoting effects of cigarette smoke on leukocytes and endothelial cells. Ann NY Acad Sci 1993; 686:112-119.
78. Lehr, HA, B Frei, and KE Arfors. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci USA 1994; 91:7688-7692.
79. Lehr, HA, E Kress, MD Menger, HP Friedl, C Hubner, KE Arfors, and K Messmer. Cigarette smoke elicits leukocyte adhesion to endothelium in hamsters: Inhibition by CuZn-SOD. Free Radic Bioi Med 1993; 14:573-581.
80. Lehr, HS, AS Weyrich, RK Saetzler, A Jurek, KE Arfors, GA Zimmerman, SM Prescott, and TM McIntyre. Vitamin C blocks inflammatory PAF mimetics created by cigarette smoking. J Clin Invest 1997; 99:2358-2364.
81. Lehr, HA, C Hubner, D Nolte, B Finckh, U Beisiegel, A Kohlschutter, and K Mebmer. Oxidatively modified human low-density lipoprotein stimulates leukocyte adherence to the microvascular endothelium in vivo. Res Exp Med 1991; 191:85-90.
82. Imaizumi, T, K Satoh, H Yoshida, H Kawamura, M Hiramoto, and S Takamatsu. Effect of cigarette smoking on the levels of platelet-activating factor-like lipid(s) in plasma lipoproteins. Atherosclerosis 1991; 87:47-55.
83. MacNee, W, B Wiggs, AS Belzberg, and JC Hogg. The effect of cigarette smoking on neutrophil kinetics in human lungs. N Engl J Med 1989; 321:924-928.
84. Terashima, T, ME Klut, D English, J Hards, JC Hogg, and SF van Eeden. Cigarette smoking causes sequestration of polymorphonuclear leukocytes released from the bone marrow in lung microvessels. Am J Respir Cell Mol Bioi 1999; 20: 171-177.
85. Kimura, H, NZ Wu, R Dodge, DP Spencer, BM Klitzman, TM McIntyre, and MW Dewhirst. Inhibition of radiation-induced up-regulation of leukocyte adhesion to endothelial cells with the PAF inhibitor, BN52021. Int J Radiat Oncol Bioi Phys 1995; 33:627-633.
86. Staprans, I, JH Rapp, X-M Pan, KY Kim, and KR Feingold. Oxidized lipids in the diet are a source of oxidized lipid in chylomicrons of human serum. Arterioscler Thromb 1994; 14: 1900-1905.
87. Staprans, I, JH Rapp, X-M Pan, and KR Feingold. The effect of oxidized lipids in the diet on serum lipoprotein peroxides in control and diabetic rats. J Clin Invest 1994; 92:638-643.
88. Staprans, I, JH Rapp, X-M Pan, DA Hardman, and KR Feingold. Oxidized lipids in the diet accelerate the development of fatty streaks in cholesterol-fed rabbits. Arterioscler Thromb Vase Bioi 1996; 16: 533-538.
89. Staprans, I, DA Hardman, X-M Pan, and KR Feingold. Effect of oxidized lipids in the diet on oxidized lipid levels in postprandial serum chylomicrons of diabetic patients. Diabetes Care 1999; 22:300-306.
90. Lewis, MS, RE Whatley, P Cain, TM McIntyre, SM Prescott, and GA Zimmerman. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial celldependent neutrophil adhesion. 1 Clin Invest 1988; 82:2045-2055.
91. Travers, JB. Oxidative stress can activate the epidermal platelet-activating factor receptor. 1 Invest Dermatol 1999; 112:279-283.
92. Patel, KD, GA Zimmerman, SM Prescott, RP McEver, and TM McIntyre. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. 1 Cell Bioi 1991; 112:749-759.
93. Vischer, UM, L lomot, CB Wollheim, and JM Theler. Reactive oxygen intermediates induce regulated secretion of von Willebrand factor from cultured human vascular endothelial cells. Blood 1995; 85: 3164-3172.
94. Xia, L, 1 Pan, L Yao, and RP McEver. A proteasome inhibitor, an antioxidant, or a salicylate, but not a glucocorticoid, blocks constitutive and cytokine-inducible expression of P-selectin in human endothelial cells. Blood 1998; 91:1625-1632.